Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick H Kim

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Journal of the American College of Cardiology|June 27, 2009
End points and clinical trial design in pulmonary arterial hypertensionVallerie V McLaughlin, David B Badesch, Marion Delcroix, et al.
Respirology (Carlton, Vic.)|April 24, 2026
Right Atrial Pressure/Pulmonary Artery Wedge Pressure Ratio Correlates With Early Outcomes After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary HypertensionCze Ci Chan, Bárbara Lacerda Teixeira, Angela Bautista, et al.
Chest|August 13, 2011
Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomyKim M Kerr, William R Auger, James J Marsh, et al.
Journal of Racial and Ethnic Health Disparities|August 5, 2025
Characteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and EthnicityHarrison W Farber, Murali M Chakinala, Anna R Hemnes, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 5, 2018
Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 studyAdaani Frost, Munir Janmohamed, Jason S Fritz, et al.
The Annals of Thoracic Surgery|September 8, 2020
Evaluation of Routine Coronary Angiography Before Pulmonary ThromboendarterectomyAmit K Pandey, Noel S Lee, Jamie Marsal, et al.
Drugs - Real World Outcomes|January 12, 2026
Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)Pilar Escribano Subias, Murali M Chakinala, Kelly M Chin, et al.
The Annals of Thoracic Surgery|June 24, 2025
Safety and Immediate Efficacy of Pulmonary Thromboendarterectomy for Chronic Thromboembolic DiseaseElizabeth M Bird, Jenny Z Yang, Edward W Mims, et al.
ERJ Open Research|July 29, 2025
Rare variants in <i>STAB2</i> in patients with chronic thromboembolic pulmonary hypertensionMark W Dodson, Kristina Allen-Brady, Jeffrey Stevens, et al.
Chest|November 19, 2019
Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway AgentsVallerie V McLaughlin, Richard Channick, Teresa De Marco, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Journal of the American College of Cardiology|June 27, 2009
End points and clinical trial design in pulmonary arterial hypertensionVallerie V McLaughlin, David B Badesch, Marion Delcroix, et al.
Respirology (Carlton, Vic.)|April 24, 2026
Right Atrial Pressure/Pulmonary Artery Wedge Pressure Ratio Correlates With Early Outcomes After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary HypertensionCze Ci Chan, Bárbara Lacerda Teixeira, Angela Bautista, et al.
Chest|August 13, 2011
Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomyKim M Kerr, William R Auger, James J Marsh, et al.
Journal of Racial and Ethnic Health Disparities|August 5, 2025
Characteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and EthnicityHarrison W Farber, Murali M Chakinala, Anna R Hemnes, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 5, 2018
Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 studyAdaani Frost, Munir Janmohamed, Jason S Fritz, et al.
The Annals of Thoracic Surgery|September 8, 2020
Evaluation of Routine Coronary Angiography Before Pulmonary ThromboendarterectomyAmit K Pandey, Noel S Lee, Jamie Marsal, et al.
Drugs - Real World Outcomes|January 12, 2026
Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)Pilar Escribano Subias, Murali M Chakinala, Kelly M Chin, et al.
The Annals of Thoracic Surgery|June 24, 2025
Safety and Immediate Efficacy of Pulmonary Thromboendarterectomy for Chronic Thromboembolic DiseaseElizabeth M Bird, Jenny Z Yang, Edward W Mims, et al.
ERJ Open Research|July 29, 2025
Rare variants in <i>STAB2</i> in patients with chronic thromboembolic pulmonary hypertensionMark W Dodson, Kristina Allen-Brady, Jeffrey Stevens, et al.
Chest|November 19, 2019
Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway AgentsVallerie V McLaughlin, Richard Channick, Teresa De Marco, et al.
Pageof 12